The European Union promotes Happy Patient to investigate patient-doctor strategies to reduce inappropriate antibiotic consumption

  14 January 2021

Up to 16 scientific, university, and clinical organizations from 8 European countries (Spain, France, Germany, Poland, Lithuania, Netherlands, Greece, Denmark, and Norway), will develop a European project over the next 3 years to generate studies, research, and training materials in the following target-countries: Spain, France, Greece, Poland, and Lithuania to prevent the incorrect and massive prescription of antibiotics at various levels of care. The start of activities is on the 1 st of January 2021.

HAPPY PATIENT aims to set an end to the arbitrary prescription of antibiotics

The HAPPY PATIENT Project is born as a response from the European Commission to address the growth of antimicrobial resistance (AMR) over the last 20 years. The project argues that «after two decades’ effort in addressing the growth of antimicrobial resistance (AMR), the urgency of the problem is now widely understood. Inappropriate use of antibiotics is the main driver for the growing development and spread of antimicrobial resistance.”

Further reading: Happy Patient
Author(s): Happy Patient
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec

JSS University

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!